CompletedPhase 2NCT03927313

Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Cape Town
Principal Investigator
Robert J Wilkinson, PhD
Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Intervention
Linezolid(drug)
Enrollment
52 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2021

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03927313 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials